On July 14, CJ MedTec announced that, together with CJ Bio, it will expand its extracellular matrix (ECM) platform technology to the adipose tissue sector and actively pursue the development and ...
L&C Bio said on the 14th that it has obtained formal approval from Peru's DIGEMID for Re2O, a human skin tissue-based ...
L&C BIO(47,450 won 1,750 -3.56%) said on the 7th that it registered a domestic patent for an injectable tissue reconstruction technology using extracellular matrix (ECM) extracted from human tendons.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results